Background Little is known about the influence of multiple sclerosis (MS) diagnosis on parenthood attitude in people with MS (pwMS). Objective To investigate the impact of diagnosis, clinical features and external disease-related influences on parenthood decision-making in Italian pwMS. Methods A web-based survey was posted on SMsocialnetwork.com to investigate clinical status, parenthood desire, influences on family planning, pregnancy outcomes, abortions and adoptions of pwMS. Results 33/395 respondents never wanted to become parent because of MS ("anti-parenthood after diagnosis"). 362 declared to be in favor of parenthood. 51% pwMS having a child by the survey time had already received the MS diagnosis at first childbirth. The frequency of a second child in pwMS after diagnosis was 38% compared to 67% in people without yet MS diagnosis. 16% of pwMS were discouraged to become parent after diagnosis, mainly by medical personnel. In 71% of respondents, diagnosis did not delay the decision to become parent and only 39% were counseled by treating physician to plan pregnancy. Patients' distribution according to the clinical phenotype (exclusively relapsing vs exclusively progressive) showed a higher proportion of progressive patients in the "anti-parenthood after diagnosis" subgroup. Conclusion MS diagnosis impacted dramatically on the life project of 7% of pwMS that decided not to have children because of the disease and in pro-parenthood pwMS impacted especially on having the second child. Only a minority was counseled to plan pregnancy. A worse disease course driving to a progressive phenotype at survey time might have negatively impacted on parenthood desire.
Introduction
Multiple sclerosis (MS) is the second leading cause of neurological disability in young adults, with a female prevalence and a disease onset in the reproductive age [1] . The new diagnostic criteria allowed the anticipation of diagnosis usually occurring in childbearing years [2] . After being diagnosed, people with MS (pwMS) must deal with the "disease representation", characterized by sudden onset, unpredictable course, disabling symptoms and uncertain prognosis, facing significant challenges regarding psychological adjustment and acceptance [3] . Accordingly, recently diagnosed pwMS and their partners frequently show a worsening quality of life with high levels of anxiety and distress [4, 5] . The emotional discomfort may negatively impact on their decision-making process [6] affecting life decisions and family planning. Growing evidence on the neutral/positive effect of pregnancy on MS, and the better knowledge on disease-modifying treatment (DMT) safety, has led to an overall risk minimization through both a better definition of drugs' cost-benefit profile [7] and the counseling process to plan pregnancy and breastfeeding [8, 9] . However, for pwMS, family planning may raise worries about the effects of pregnancy on disease course, about the heredity of MS, and about fetal or pediatric safety related to DMT assumption at the time of conception, during pregnancy and breastfeeding. Although the advances on knowledge about the reciprocal effect of pregnancy and MS might have contributed to encourage pwMS on family planning, the frequency of childlessness in pwMS is higher than in the general population and the association between nulliparity and MS tends to increase with age [10] . A large study, focused on reproductive attitudes and behavior of North American pwMS, highlighted some deep-seated concerns such as inadequate parenting abilities, passing on MS to the child and possible risks associated with exposure to medications during pregnancy [11] . A recent study, reporting the results of an online survey investigating pwMS awareness about family planning, showed that the 30% of respondents did not have children and that, among these, the 50% wanted to start a family, with no significant difference between respondents with high disease activity being less likely to want to start a family than respondents with lower disease activity [12] . To our knowledge, little is known about the putative influence of diagnosis and disease status processing on parenthood desire and realization in Italian pwMS.
Objective
To better understand the factors influencing Italian pwMS' family planning process we designed a web-survey investigating (1) the impact of diagnosis, clinical features and external disease-related influences on parenthood decision-making and (2) the mismatch between this desire and the effective children birth.
Methods

Web-based survey and SMsocialnetwork
We posted on the public wall of SMsocialnetwork.com a web-based 26-item survey, created with the collaboration of a group of neurologists and psychologists of the First Clinic of Neurology of the University of Campania "Luigi Vanvitelli", with expertise in MS and web. The five main interest areas of the survey were (1) social and clinical status, (2) parenthood desire, (3) external influences during the elaboration phase of family desire, (4) pregnancy outcomes and (5) abortions and adoptions.
The survey was posted from November to December 2016 on the public wall of http://www.SMsoc ialne twork .com, a Facebook-like social network completely dedicated to pwMS and supervised by a team of neurologists and psychologists [13] . The survey was displayed in a popup window when visitors accessed to the website (the full Italian version is available in Supplemental Material). To gauge the recruitment bias via online survey, we compared the main characteristics (age, M/F ratio) of respondents to the corresponding data from the "Barometro 2018" (https ://www.aism.it/ index .aspx?codpa ge=2018_barom etro_scler osi_multi pla) from the Italian Association of Multiple Sclerosis (AISM) which gives a snapshot on multiple sclerosis in Italy in 2017; furthermore, regarding age at first child birth of women with MS we compared the age at first child birth of our sample with the mean age at first child birth of the general population of Italian women from ISTAT (Italian Public Institute of Statistics) (https ://www.istat .it/it/files //2011/10/testo integ rale2 00807 011.pdf).
Registration, pwMS consent and privacy policy
The study was performed in accordance with good clinical practice and the Declaration of Helsinki. All participants consented to the use of recorded surveys for scientific purposes on aggregate level. To protect the anonymity of the participants, the Internet protocol codes of the computers were not registered, and no electronic "cookies" were embedded.
We followed the directive 95/46/ec of the European Parliament and of the Council of October 24, 1995, on the protection of individuals regarding the processing and free transfer of personal data (https ://eur-lex.europ a.eu/legal -conte nt).
Statistical analysis
All pwMS' answers, anonymously transferred to an electronic database, were analyzed using the STATA version 14.1 software package (StataCorp, College Station, Texas, http://www.stata .com). Continuous variables were described as relative frequencies, medians or means and standard deviations (SD). The Chi-square test, or when necessary the Fisher's exact test, was used for testing correlation among the categorical variables. Student's t test and one-way analysis of variance (ANOVA) were used to compare parametric data, respectively, between two or among more groups. The Bonferroni correction was applied to any post hoc comparison of frequencies or averages. A p value lower than 0.05 was considered statistically significant.
Results
We collected 519 surveys and considered 484 of them, excluding
• 35 for missing data (surveys with > 20% of missing answers) [14] .
Of note, not being mandatory to answer to each item, the number of respondents to each item might vary.
The study sample consisted of 345/484 (71%) of women with a mean (SD) age of 40.8 (10.5) years at the time of the survey. 462/484 (95%) answered to the item investigating the years of education; among these 407/462 (88%) were predominantly highly educated with at least 13 years of education. The mean (SD) age at MS onset and diagnosis were, respectively, 27.7 (8.9) and 30.7 (9.5) years.
When comparing our sample to the MS population reported by the "Barometro 2018", respondents had a mean age of 40.8 vs 46 years of the "Barometro" pwMS; F/M ratio was 2.7 in our population vs 2.3 in the "Barometro" one.
377/484 (78%) answered to the item investigating the presence of relapses and 286/377 (75%) stated to have a relapsing MS phenotype. 373/484 (77%) answered to the item investigating about the presence of progression and 151/373 (40%) confirmed to have progression. The two answers about relapses and progression were not mutually exclusive.
474/484 (98%) answered to the item investigating the walking ability and 284/474 (60%) declared to walk more than 500 m without assistance or resting.
462/484 (95%) answered to the item investigating therapies with DMTs at the time of the survey, and 231/462 (50%) of pwMS were, according to the Italian Pharmaceutical Agency (Agenzia Italiana del farmaco, AIFA, https ://www. agenz iafar maco.gov.it), in first-line DMTs, 141/462 (30.5%) in second-line DMTs and 90/462 (19.5%) were therapy free or in other therapies (see Table 1 ).
Patient stratification
Analyzing the answers to the critical 13th item of the survey (Q13: "How old were you when you decided to become parent?"), we performed a sample stratification according to the desire to become parent ("pro-parenthood").
122/484 (25%) of respondents declared not to desire to become parent ("anti-parenthood").
89/122 (73%) declared not to desire to become parent for not-MS-related reasons ("anti-parenthood for their own reasons") and 33/122 (27%) never wanted to become parent because of MS ("anti-parenthood after diagnosis"). The subgroup "anti-parenthood for their own reasons" was excluded from any further analyses because it was not contributory to the aim of our study. Therefore, our sample consisted of 395 pwMS.
Pro-parenthood subgroups
The "pro-parenthood" had a mean age of 41.7 (SD 9.2) years at the survey time.
362/395 (92%) declared to be in favor of parenthood ("pro-parenthood"). Of them, 358/362 (99%) answered to the item "have you been diagnosed with MS when you decided to become a parent?" while 4 pwMS gave no answer to this item.
Among these 358 pwMS, 167/358 (47%) had already received the diagnosis of MS at decision time ("pro-parenthood after diagnosis") while 191/358 (53%) were still unaware of the upcoming disease ("pro-parenthood before diagnosis") (see Fig. 1 ).
343/358 (96%) "pro-parenthood" answered to the item "by the time of this survey, do you have a child?" and, among these, 291/343 (84%) answered positively, while 52/343 (16%) gave a negative answer. Among these 291 pwMS having a child by the survey time, 286 answered to the item "Had you been already diagnosed with MS at the time of first child birth?" and 5 pwMS did not respond;
147/286 (51%) had already received the MS diagnosis while 139/286 (49%) did not receive the MS diagnosis (see Fig. 2 ).
Frequency of a second child
Among the 147 respondents already diagnosed with MS at the time they had the first child, 131 answered to the item "Do you have a second child?"; of them 51/131 (38%) answered positively and 80/131 (62%) answered negatively. Among the 139 respondents that were not yet diagnosed with MS at the time they had the first child, 125 answered to the item "Do you have a second child?"; of them 83/125 (67%) answered positively and 42/125 (33%) answered negatively. Among those 83 pwMS who had the second child, 70/83 (85%) were still without the MS diagnosis and 13/83 (15%) had been already diagnosed with MS (see Fig. 2 ).
The frequency of a second child in pwMS after diagnosis was 38% compared to 67% in people without yet the MS diagnosis (see Fig. 2 ).
Frequency of a third child
Among pwMS having had two children and already diagnosed by the time of the first child, 32/51 answered to the item "Do you have a third child?"; of them, 8/32 (25%) answered positively and 24/32 (75%) answered negatively. Among those 13/83 pwMS who had been diagnosed between the first and second childbirth, 7/13 answered to the item "Do you have a third child?"; of them, 3/13 answered positively and 4/13 answered negatively (see Fig. 2 ).
Working status and education
In "pro-parenthood", only 54/362 (15%) pwMS answered to the item investigating about working activity and 22/54 (41%) were employed; only 55/362 (15%) pwMS answered about the item on education and 25/55 (45%) declared 13 years of school and 18/55 (33%) > 13 years.
Discouragement to become parent
Among "pro-parenthood", 349/362 (96%) answered to the item "After MS, have you been discouraged to become parent?"; of them, 55/349 (16%) were discouraged to become parent after diagnosis, more frequently by medical personnel (neurologist/physician), mainly due to concerns for the effects of pregnancy on MS. PwMS discouraged to become parent were more frequently women, significantly older by the survey time and younger at diagnosis with respect to not discouraged pwMS (see Table 2 ); 28/55 had already a child when discouraged and 27/55 had no children. Among 55 pwMS that were discouraged to have children, 45/55 answered the item investigating about DMT intake when they were discouraged; among them 20/45 pwMS were treated either with glatiramer acetate or interferons, 15/45 were treated with drugs considered potentially unsafe during pregnancy (teriflunomide, cyclophosphamide, fingolimod, alemtuzumab, dimethylfumarate and natalizumab) and 10/45 were under "other" treatment.
Delay of decision to become parent
In "pro-parenthood after diagnosis", 118/167 (71%) admitted that the diagnosis did not delay the decision to become parent.
164/167 (98%) answered the item investigating which DMT was taken by the time of parenthood decision and 86/164 (52%) declared to be treated with interferon beta or glatiramer acetate (DMTs considered "safe" for pregnancy) and 34/164 (21%) declared not to be treated.
Pregnancy planning
In the "pro-parenthood" group, 311/362 (86%) answered the item "Did your physician advise you to plan pregnancy?"; only 123/311 (39%) were counseled by their treating physician to plan pregnancy and to avoid unplanned pregnancy (no significant differences in level of education were found between pwMS advised (123) and those not advised (188) to plan pregnancy, p = 0.094). 115/123 of pwMS counseled to plan pregnancy answered to the item investigating whether they had children or not: 25/123 did not have and 90/123 pwMS did have children; 31/90 had the first child before having been diagnosed with MS and 59 after being diagnosed with MS. Therefore, in our sample, we have 31 pwMS with already a child when they were advised to plan pregnancy.
Age at first child: "pro-parenthood after diagnosis" vs "pro-parenthood before diagnosis"
Age at 1st child birth was higher in the "pro-parenthood after diagnosis" than in "pro-parenthood before diagnosis", respectively, 32.2 (5.3) vs 27.9 (5.1) years, p < 0.001; this difference was still significant after adjusting for age at diagnosis ("pro-parenthood after diagnosis" 34.6 (0.6) vs "proparenthood before diagnosis" 26.6 (0.5), p < 0.001).
We compared the age at first child birth of our sample with the mean age at first child birth of the Italian women from ISTAT (https ://www.istat .it/it/files //2011/10/testo integ rale2 00807 011.pdf): our sample of women with MS who had the first child after diagnosis were older compared to general population of Italian women (32.1 vs 31.4); however, because we do not have a SD for the ISTAT data we cannot conclude whether this difference is significant or not. Considering factors potentially influencing the age at first child birth, we performed a further analysis correcting for age at diagnosis, comparing age at first child in the "pro-parenthood before" and "pro-parenthood after diagnosis" according to disease phenotype (only relapsing or only progressive), and walking distance > or < to 500 m: for any comparison, age at 1st child was significantly higher in the "pro-parenthood after diagnosis" subgroup (see Table 3 ).
Adoptions
In the "pro-parenthood" group, 348/362 (96%) answered the question "Have you considered to adopt a child?" and only 92/348 (26%) of them considered child adoption, especially for a personal or health-related choice independent of MS. Otherwise 256/348 (74%) did not consider child adoption mainly (200/256 [78%]) for reasons independent of MS. Only 272/348 (78%) answered to the item "have you adopted a child?"; of them, only 4/272 (1.5%) really adopted a child, for a personal choice not disease-related.
Abortions
321/362 (89%) "pro-parenthood" answered the item "Did you have abortions" and 80/321 (25%) had abortions. Of them, 69/80 (86%) answered to the item "Was the abortion spontaneous or voluntary" and 51/69 (74%) reported at least a spontaneous abortion, mainly in the first trimester of pregnancy. 29/321 (9%) of "pro-parenthood" performed at least a voluntary termination of pregnancy. Among the 29 pwMS who had a voluntary abortion, 3pwMS did not have children; 12/26 had at least a child before MS diagnosis, 13/26 had at least a child after diagnosis and 1 pwMS did not answer at the item investigating the timing of diagnosis with respect to the first child birth.
Relapsing and progressive sub-analysis
377/395 (95%) answered the item investigating about the presence of relapses and 286/377 (76%) stated to have a relapsing MS phenotype at survey time. 373/395 (94%) answered the item investigating about the presence of progression and 151/373 (40%) reported to have a progressive course of the disease (see Fig. 3a ). The two answers about relapses and progression were not mutually exclusive. Among 286 relapsing pwMS, 21/286 (7%) belonged to the subgroup "anti-parenthood after diagnosis"; 139/286 (49%) were in "pro-parenthood after diagnosis" subgroup; 126/286 (44%) were in "pro-parenthood before diagnosis" subgroup. 91/377 (24%) respondents declared not to have relapses. 18 people did not answer the item Q8 investigating the presence of relapses; of them, 15/18 did answer the item Q9 investigating the presence of progression and 13/15 stated to be progressive while 2/15 declared not to be progressive. Among those answering "yes" (74 + 13) to item Q9 about progression, 12/87 (14%) were in the "antiparenthood after diagnosis" subgroup; 22/87 (25%) were in "pro-parenthood after diagnosis" subgroup; 53/87 (61%) were in "pro-parenthood before diagnosis" subgroup (see Fig. 3a ). Considering those people answering to have only a relapsing or only a progressive phenotype, 222 patients were only relapsing and 87 were only progressive while 64 were both relapsing and progressive (see Fig. 3a ). The patients' distribution according to the clinical phenotype (exclusively relapsing vs exclusively progressive) was significantly different (p < 0.001) in the three subgroups considering the parenthood desire ("anti-parenthood after diagnosis", "proparenthood before" and "pro-parenthood after diagnosis") showing a higher proportion of progressive patients in the "anti-parenthood after diagnosis" subgroup (see Fig. 3b ).
373/395 (94%) pwMS replied to the item Q9 "presence/ absence of progression", referring to their clinical phenotype at the time of the survey and 151/373 (40%) declared a progressive course: 18/151 (12%) belonged to the "antiparenthood after diagnosis" subgroup; 52/151 (34%) were in "pro-parenthood after diagnosis" subgroup; 81/151 (54%) were in "pro-parenthood before diagnosis" subgroup (see Fig. 3b ).
"Anti-parenthood after diagnosis" vs "pro-parenthood after diagnosis"
• The "anti-parenthood after diagnosis" had a mean age at onset and diagnosis significantly higher than the "proparenthood after diagnosis" (respectively, 26.3 vs 23.6, p = 0.016; 29.2 vs 25.2, p = 0.001); • the age at diagnosis was inversely correlated with the pro -parenthood attitude (OR 0.90, CI 95% 0.85-0.96 p = 0.001); • the age at diagnosis was positively correlated with the age at 1st child birth in "pro-parenthood after diagnosis" (r = 0.55 p < 0.001) also in "pro-parenthood before diagnosis" but with a weaker correlation (r = 0.19 p = 0.016); • the educational level was not significantly different (p = 0.423);
• a lower percentage of "anti-parenthood after diagnosis" compared to "pro-parenthood after diagnosis" declared to walk over 500 m without rest or assistance (45.5% vs 68.5 p = 0.012); • The age for pwMS needing a walking support was not significantly different (p = 0.286); • see Fig. 3a , b for patients' distribution in the "pro-parenthood before diagnosis", "pro-parenthood after diagnosis" and in the "anti-parenthood after diagnosis" subgroups according to clinical course. 
Discussion
Our survey study, recruiting members of a web community supervised by Neurologists and Psychologists, explored the parenthood motivation in a subgroup of 395 Italian pwMS interested in parenting issues. Despite having addressed the survey to both sexes, recognizing their mutual role in reproductive decisions, participants were principally women, as consistent with the predominant female susceptibility to MS [1] . The majority of respondents were (1) not in an advanced stage of illness, as shown by a prevalent relapsing-remitting course; (2) not reporting walking restriction; (3) using (in about half of the cases) a first-line DMT, according to AIFA (https :// www.agenz iafar maco.gov.it). Despite the reassuring data on pregnancy in pwMS, our results showed that about 7% (33) of respondents of our sample declared that they never wanted to become parent because of MS, being representative of the most dramatic impact of diagnosis on life project. In agreement with previous studies [15, 16] , although only a small percentage of pwMS reported to have been frankly discouraged to procreate after the diagnosis, more frequently the negative influences were provided by medical personnel (physician/neurologist) for concerns about the effects of pregnancy on MS. Furthermore, our data highlighted and confirmed a gap in the doctor-pwMS communication on reproduction, pregnancy, and childbearing issues [8, 9] . In fact, solely a minority of participants received doctor counseling to plan pregnancy or to avoid accidental maternity. In this respect, in our sample, having had a child before or after MS diagnosis was not a major issue to advise or not to plan pregnancy. A minority of participants reported abortions: most of them occurred spontaneously during the first trimester of pregnancy, in accordance with previous studies revealing not increased rate of miscarriages in MS women [17] . Only a small number of participants, concerned about the inability to raise the baby, reported induced abortions differently from a recent survey where the reasons of the medical/surgical abortions were unclear [12] . We considered reliable these findings as the web tool may represent a comforting space to debate on disease-related concerns overcoming the inconvenience of pwMS-doctor frontal approach [18] . It is worthwhile to consider that the pro-parenthood or anti-parenthood attitude refers to the desire of becoming parents, independently by the concrete realization of this desire; in the study definition, "anti-parenthood" are those people who never desired to become parents: either for personal reasons (and these patients were excluded from the analyses) or for MS-related reason; therefore, women having an abortion may be still "pro-parenthood" but may decide to have an abortion for several reasons (being unmarried, interference with job stabilization, unstable relationship with partner, economic problems, etc.).
In our MS sample was also confirmed the low propensity for adoption observed in the general Italian population (http://www.centr ostud inisi da.it/Stati stica /Adozi one_affid ament o.html).
Different from previous studies [8, 19] , only a small percentage of our population rejected parenting as a disease consequence; indeed, 51% of the respondents had already received the MS diagnosis at the time of becoming parent for the first time while 49% had not yet been diagnosed with MS. However, among those having had a second child, 85% did not know to have MS and 38% were already diagnosed, showing a decrease in frequency of second child after the diagnosis of MS. This result is in agreement with the findings of a Portuguese study where the planned pregnancy number of MS women decreased immediately after the diagnosis, suggesting important implications of disease disclosure on life projects [20] .
Considering the significant difference between the proportion of relapsing and progressive patients in the "anti-parenthood" subgroup (7% vs 14%), in the "proparenthood" after diagnosis subgroup (49% vs 25%) and in the "pro-parenthood" before diagnosis (44 vs 61%), we suggest that a worse disease course, that drove to a progressive phenotype at survey time, might have negatively impacted on parenthood desire, probably triggering a prospective fear of "worsening" in the near future.
Supporting this evidence, in our study, we found that not-relapsing pwMS, with a positive attitude towards parenthood, more frequently elaborated the desire for family before the diagnosis. Moreover, we found that "anti-parenthood after diagnosis" were older than the "pro-parenthood after diagnosis" (respondents who processed the decision to become parent after receiving the diagnosis) at disease onset and diagnosis, showing an inverse correlation between age at diagnosis and parenthood attitude. These results suggested that, considering the MS age at diagnosis ranging from 20 to 40 years old, a later onset and diagnosis could negatively interfere with the development of parenthood desire and motivation. Moreover, younger pwMS might have a better copying with the disease, with a better perceived QoL [21] , and through the mitigating role of resiliency [22] .
PwMS in "pro-parenthood after diagnosis" subgroup declared that the disease awareness did not delay the desire to become parent; probably the prevalence of interferon beta or glatiramer acetate in this population or the complete lack of exposure to medications, at the moment of parenthood choice, might have influenced the result; indeed, we can speculate that pwMS requiring a first-line DMT might have had a better disease course thus not impacting on their parenthood decision.
Limits
An important limitation of this survey is part of the general limitation of Social Networking Sites for collecting data that may introduce self-selection bias, with consequent generalization issues; however, to gauge any bias in recruitment, we compared the demographic characteristics (age, F/M ratio) of our sample to data from the "Barometro-2018" of AISM.
The current study design was a cross-sectional survey and hence subject to selection, recall, and information bias. It may represent the patient voice, but the data are based on subjective self-reports, and are derived from a convenience sample. Furthermore, the mix of patients is representative of SMsocialnetwork and not necessarily of the MS population at large.
In contrast to face-to-face interview, online surveys do not allow to deepen the reasons leading to each choice in the answers and to have complete information from any respondent; on the other side, online surveys allow to involve many people in a short time.
Another important limitation is the lack of a healthy control group which could have strengthened some of the conclusion; however, we tried to overcome some criticality due to this lack by comparing some data to data derived from ISTAT referring to the Italian general population.
Conclusions
In conclusion, in our sample, MS diagnosis may overlap with the timeframe of parenthood decision interfering with the elaboration of family desire and its realization. The process of psychological acceptance and adjustment, after the diagnosis of MS, requires a time to overcome the negative representation of the disease by implementing coping strategies for positive adaptation [23, 24] . In particular, MS diagnosis impacted dramatically on the life project of 7% of our sample that decided not to have children because of the disease; moreover, our data suggest that dealing with MS impacted more on having the second child than the first one.
The negative influences on family planning were provided mainly by medical personnel (physician/neurologist) for concerns about the effects of pregnancy on MS. Therefore, a prompt and skilled counseling focused on parenthood-related issues may support the tuning into needs of pwMS, encouraging parenting. Hence, in accordance with a recent study that showed that 47% of respondents to an online survey felt inadequately informed about treatment possibilities for MS while planning to start a family [12] , our data suggest that an adequate informed support of pwMS is necessary, especially right after the diagnosis, to reduce the negative impact of an inappropriate disease awareness on parenthood motivation and life decisions.
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